FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ezetimibe/Atorvastatin (LIPTRUZET)
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Merck Sharp & Dohme Corp. (New 06/02/2015)

Company Contact Information:
800-672-6372

Presentation Posting Date Related Information
Ezetimibe 10 mg/ Atorvastatin 10 mg unit of use packages of 90 (three cartons each containing one multi-fold wallet with two 15-count blister cards) Tablets (NDC 0006-0257-03) 06/02/2015 This decision is business-related and not based on any safety or efficacy findings with this product.
Ezetimibe 10 mg/ Atorvastatin 10 mg unit of use packages of 90 (three cartons each containing one multi-fold wallet with two 15-count blister cards) Tablets (NDC 0006-0257-03) 06/02/2015 This decision is business-related and not based on any safety or efficacy findings with this product.
Ezetimibe 10 mg/ Atorvastatin 20 mg unit of use packages of 30 (one carton containing one multi-fold wallet with two 15 count blister cards) (NDC 006-0333-02) 06/02/2015 This decision is business-related and not based on any safety or efficacy findings with this product.
Ezetimibe 10 mg/ Atorvastatin 20 mg unit of use packages of 90 (three cartons each containing one multi-fold wallet with two 15-count blister cards) Tablets (NDC 0006-0333-03) 06/02/2015 This decision is business-related and not based on any safety or efficacy findings with this product.
Ezetimibe 10 mg/ Atorvastatin 40 mg unit of use packages of 30 (one carton containing one multi-fold wallet with two 15count blister cards) (NDC 0006-0337-02) 06/02/2015 This decision is business-related and not based on any safety or efficacy findings with this product.
Ezetimibe 10 mg/ Atorvastatin 40 mg unit of use packages of 90 (three cartons each containing one multi-fold wallet with two 15-count blister cards)(ndc 0006-0337-03) 06/02/2015 This decision is business-related and not based on any safety or efficacy findings with this product.
Ezetimibe 10 mg/ Atorvastatin 80 mg unit of use packages of 30 (one carton containing one multi-fold wallet with two 15count blister cards)(NDC 0006-0357-02) 06/02/2015 This decision is business-related and not based on any safety or efficacy findings with this product.
Ezetimibe 10 mg/ Atorvastatin 80 mg unit of use packages of 90 (three cartons each containing one multi-fold wallet with two 15-count blister cards)(NDC 0006-0357-03) 06/02/2015 This decision is business-related and not based on any safety or efficacy findings with this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English